Cite

HARVARD Citation

    Szlachta, K. et al. (2018). CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Nature communications. 9 (1), pp. 1-13. [Online]. 
  
Back to record